Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP in Open Surgery for Type A Aortic Dissection
NCT07005661Phase 3Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jun 2025
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
01
Overview
Phase 3, randomised, double-blind trial of autologous platelet rich plasma gel + autologous platelet rich plasma injection in aortic dissection (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Units of Allogeneic RBC Transfusion Within 24 Hours Perioperatively. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
autologous platelet rich plasma gel + autologous platelet rich plasma injection
03
Conditions
aortic dissection
Beyond the preview
Go deeper on NCT07005661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07005661.